1398.2000 10.20 (0.73%)
NSE Nov 18, 2026 15:31 PM
Volume: 1.3M
 

1398.20
0.73%
Emkay
Dr Reddy's has disclosed that it has halted commercial supplies of Semaglutide with the recently scaled-up batch being found to be out of specification due to an issue associated with an impurity.
Dr. Reddy's Laborato.. has an average target of 1335.44 from 9 brokers.
More from Dr. Reddy's Laboratories Ltd.
Recommended